A remarkable event is taking place at Sanlongwan Sci-Tech City as Nobel laureates and esteemed scientists from the Chinese Academy of Sciences gather together to address a recent global health concern. The focus of the event is Helicobacter pylori, a common bacterium infecting over 50% of the world's population, with China experiencing an infection rate of 58.07%.

Helicobacter pylori is known to be a major cause of gastric cancer, leading to the loss of around 200,000 lives in China every year. Recognizing the severity of this issue, renowned researcher Professor Barry J. Marshall, widely recognized as the leading expert on Helicobacter pylori, will lead the conference.

On July 8, prestigious institutions including the Helicobacter Laboratory at the University of Western Australia led by Professor Barry J. Marshall, and the Key Laboratory of Molecular Virology and Immunology at the Chinese Academy of Sciences, will gather at the Guangdong Science Kehui Science and Technology Industrial Center for the signing ceremony of cooperative agreements and the launching ceremony of the Sanlongwan Sino-German Biomedical Industry Park.

Professor Barry J. Marshall, the winner of the 2005 Nobel Prize in Physiology or Medicine, was elected as a member of the US National Academy of Sciences in 2008, a foreign member of the Chinese Academy of Engineering in 2011, and was awarded the China Friendship Award by the State Council in 2015. His groundbreaking research proved that Helicobacter pylori is the main cause of most gastric ulcers and gastritis, revolutionizing decades of erroneous medical treatment and diagnosis, and is regarded as a milestone in the field of gastroenterology research.

The University of Western Australia is one of Australia's most historical, representative, and powerful research universities. In the 2022 U.S. News World University Rankings, the University of Western Australia ranked 83rd globally. The Marshall Centre and Helicobacter Laboratory led by Professor Barry J. Marshall currently have 40 international top scholars and researchers, and have established partnerships with 60 research institutions worldwide, including the US National Academy of Sciences. There are currently more than 200 medical experts and full-time researchers.

Professor Barry J. Marshall

By signing cooperative agreements and launching the Sanlongwan Sino-German Biomedical Industry Park, Foshan aims to become a hub for cutting-edge biomedical research and innovation. The Guangdong Kehui Life Science and Technology Industrial Center provides a great platform for advancing biomedical and vaccine-related developments.

This event marks a major milestone in Foshan's path towards high-quality biopharmaceutical development. By joining forces with top international research teams and establishing advanced biomedical labs and vaccine research institutes, Foshan is poised to become a global leader in the field.

Jointly supported by Shunde District, the center focuses on attracting businesses in the biopharmaceutical, medical device, and bio-environmental industries. The center strives to be a leading platform for manufacturing biomedical products and precision medical equipment in Foshan and the Pearl River Delta, offering high standards and comprehensive services.

Located in Sanlongwan Sci-Tech City, the Guangdong Kehui Life Science and Technology Industrial Center covers a total area of 230,000 square meters and serves as a multifunctional hub for research, development, and production. The center is dedicated to develop biopharmaceuticals and precision medical equipment manufacturing. It offers comprehensive services to support the growth of biomedical companies, including business services, technology transfer platforms, and financial support systems.

With global scientific research powerhouses selecting the Guangdong Kehui Life Science and Technology Industrial Center as their preferred destination, Foshan is set to embrace a new era of biomedical excellence, propelling the city to the forefront of the global biomedical research and vaccine development.

Reporter | Linn

Revisor | Christy, Eleanor

Photo | Foshan News and Media Center